Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRNX

Crinetics Pharmaceuticals Inc

May 05 • 04:00PM ET

40.75

-0.50 -1.21 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: NBIX LLY PFE NVS BMRN VRTX REGN SNY MRK BMY

| Held by: VTI IWM VB VBK VXF IWO IBB SCHA VTWO IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.94	Insider Own	6.89%	Shs Outstand	104.70M	Perf Week	6.82%
Market Cap	4.27B	Forward P/E	-	EPS next Y	-4.13	Insider Trans	-2.04%	Shs Float	97.49M	Perf Month	8.09%
Enterprise Value	3.29B	PEG	-	EPS next Q	-1.22	Inst Own	113.70%	Short Float	13.12%	Perf Quarter	-18.43%
Income	-465.32M	P/S	554.12	EPS this Y	2.86%	Inst Trans	3.70%	Short Ratio	11.43	Perf Half Y	-6.32%
Sales	7.70M	P/B	3.93	EPS next Y	14.07%	ROA	-32.52%	Short Interest	12.80M	Perf YTD	-12.46%
Book/sh	10.38	P/C	4.15	EPS next 5Y	20.70%	ROE	-40.17%	52W High	57.99 -29.73%	Perf Year	21.10%
Cash/sh	9.82	P/FCF	-	EPS past 3/5Y	-16.20% -15.33%	ROIC	-45.00%	52W Low	25.83 57.76%	Perf 3Y	82.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.56% -	Gross Margin	35.47%	Volatility	4.59% 3.89%	Perf 5Y	138.58%
Dividend TTM	-	EV/Sales	426.93	EPS Y/Y TTM	-33.52%	Oper. Margin	-6714.77%	ATR (14)	1.71	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.30	Sales Y/Y TTM	-	Profit Margin	-6046.22%	RSI (14)	58.85	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	12.32	EPS Q/Q	-46.61%	SMA20	3.51%	Beta	0.28	Target Price	83.36
Payout	-	Debt/Eq	0.05	Sales Q/Q	-	SMA50	5.98%	Rel Volume	0.82	Prev Close	41.25
Employees	594	LT Debt/Eq	0.04	Earnings	May 07 AMC	SMA200	-0.05%	Avg Volume	1.12M	Price	40.75
IPO	Jul 18, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.30% 37.22%	Trades		Volume	916,578	Change	-1.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)